Prasol Chemicals has received the Securities and Exchange Board of India’s (SEBI) approval to raise Rs 800 crore through an initial public offering (IPO). The company, which filed the draft red herring prospectus with the SEBI in April 2022, got the regulator’s approval on August 23, 2022.
The proceeds from the fresh issue to the tune of Rs 160 crore will be used for payment of debt and Rs 30 crore for working capital requirements. Besides, funds will be used for general corporate purposes. JM Financial and DAM Capital Advisors are the book-running lead managers to the issue.
Prasol Chemicals is among the leading forward integrated manufacturers of acetone derivatives and phosphorous derivatives in India. Its products have end uses in four segments namely pharmaceuticals, agrochemicals, home and personal care and performance chemicals.
| Company Name | CMP |
|---|---|
| BASF India | 3611.60 |
| Tata Chemicals | 690.25 |
| SRF | 2471.15 |
| Pidilite Inds. | 1360.30 |
| Deepak Nitrite | 1465.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: